The emerging role of brachytherapy in the management of patients with breast cancer

Seminars in Radiation Oncology

Volumn 12, Issue 1, 2002, Pages 31-39

  Vicini, Frank ^a,b   Baglan, Kathy ^a   Kestin, Larry ^a   Chen, Peter ^a   Edmundson, Gregory ^a   Martinez, Alvaro ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; IRIDIUM 192;

BRACHYTHERAPY; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; REVIEW; SAFETY;

EID: 0036150073     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.28662     Document Type: Article

References (58)

1. Breast brachytherapy
2. Brachytherapy in the treatment of breast cancer
3. Brachytherapy and breast cancer
4. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: Preliminary results of a pilot trial
5. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy
6. Accelerated treatment of breast cancer
7. Sole brachytherapy of the tumor bed after breast conserving surgery: A new radiotherapeutic strategy for patients at low risk of local relapse
8. A tumoragy egyeduli brachyterapiaja emlomegtarto mutet utan: Uj sugarterapias lehetoseg a korai emlorak kezeleseben
9. Brachytherapy as the sole method of breast irradiation in TIS, T1, T2, N0-1 breast cancer
10. Exclusive brachytherapy after conservative surgery in cancer of the breast
11. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T (is,1,2) breast cancer
12. Method of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer
13. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: A pilot study
14. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer
15. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial
16. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial
17. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France
18. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy
19. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy
20. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy
21. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy
22. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: A nonrandomized comparison
23. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: Analysis of 289 cases
24. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique?
25. High-dose-rate brachytherapy for early breast cancer: An ambulatory technique
26. Conservative treatment for breast cancer: Long-term results (15 years)
27. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer
28. Early breast cancer: Influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy
29. Interstitial high-dose-rate brachytherapy boost: The feasibility and cosmetic outcome of a fractionated outpatient delivery scheme
30. The 'boost' in the treatment of early-stage breast cancer: Electrons versus interstitial implants
31. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant
32. Iridium-192 implants for primary breast cancer: Experience with placement at the time of wide local excision
33. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma
34. Late cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes of cosmetic failure
35. Breast boost - Why, how, when...?
36. Brachytherapy and breast cancer
37. Clips and scar as the guidelines for breast radiation boost after lumpectomy
38. The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast
39. A simple method of obtaining equivalent doses for use in HDR brachytherapy
40. Implementation of 3D-virtual brachytherapy in the management of breast cancer: A description of a new method of interstitial brachytherapy
41. Iridium implant treatment without external radiotherapy for operable breast cancer: A pilot study
42. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer
43. The Christie Hospital breast conservation trial: An update at 8 years from inception
44. Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial
45. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: Results from a randomized trial
46. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer
47. Patterns of breast relapse following breast conserving surgery and radiotherapy
48. 5-Year results of a prospective phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in TIS, T1, T2, N0-1 breast cancer
49. Improving the dosimetric coverage of interstitial high-dose-rate breast implants
50. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer
51. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T (is,1,2) breast cancer
52. Interstitial high-dose-rate brachytherapy boost: The feasibility and cosmetic outcome of a fractionated outpatient delivery scheme
53. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer